Publication | Open Access
Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086
183
Citations
0
References
2017
Year
Breast OncologyCancer ImmunosurveillanceMedicineImmunologyTumor ImmunityImmune Checkpoint InhibitorBreast CancerCancer TreatmentOncologyRadiation OncologyTumor Microenvironment
No additional data available for this publication yet. Check back later!